Unknown

Dataset Information

0

Genome editing with natural and engineered CjCas9 orthologs.


ABSTRACT: CjCas9 is one of the smallest CRISPR-associated (Cas9) nucleases for mammalian genome editing. However, it requires a long N4RYAC (R = A or G; Y = C or T) protospacer-adjacent motif (PAM), limiting its DNA targeting scope. In this study, we investigated the PAMs of three CjCas9 orthologs, including Hsp1Cas9, Hsp2Cas9, and CcuCas9, by performing a GFP-activation assay. Interestingly, Hsp1Cas9 and CcuCas9 recognized unique N4RAA and N4CNA PAMs, respectively. We further generated an Hsp1Cas9-Hsp2Cas9 chimeric Cas9 (Hsp1-Hsp2Cas9), which recognized a simple N4CY PAM. Genome-wide off-target analysis revealed that Hsp1-Hsp2Cas9 has very few off-targets compared to SpCas9. By analyzing the crystal structure of CjCas9, we identified eight mutations that can improve the specificity and generate a high-fidelity Hsp1-Hsp2Cas9-Y. Hsp1-Hsp2Cas9-Y enables the knockout of B4GALNT2 and CMAH in porcine fetal fibroblasts (PFFs). Moreover, we developed a high-fidelity Hsp1-Hsp2Cas9-KY which displayed undetectable off-targets revealed by GUIDE-seq at four tested loci. These natural and engineered Cas9 nucleases enabled efficient genome editing in multiple mammalian cells, expanding the DNA targeting scope.

SUBMITTER: Gao S 

PROVIDER: S-EPMC10124074 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genome editing with natural and engineered CjCas9 orthologs.

Gao Siqi S   Wang Yao Y   Qi Tao T   Wei Jingjing J   Hu Ziying Z   Liu Jingtong J   Sun Shuna S   Liu Huihui H   Wang Yongming Y  

Molecular therapy : the journal of the American Society of Gene Therapy 20230201 4


CjCas9 is one of the smallest CRISPR-associated (Cas9) nucleases for mammalian genome editing. However, it requires a long N<sub>4</sub>RYAC (R = A or G; Y = C or T) protospacer-adjacent motif (PAM), limiting its DNA targeting scope. In this study, we investigated the PAMs of three CjCas9 orthologs, including Hsp1Cas9, Hsp2Cas9, and CcuCas9, by performing a GFP-activation assay. Interestingly, Hsp1Cas9 and CcuCas9 recognized unique N<sub>4</sub>RAA and N<sub>4</sub>CNA PAMs, respectively. We fur  ...[more]

Similar Datasets

| S-EPMC4786910 | biostudies-other
| S-EPMC7220826 | biostudies-literature
| S-EPMC6362571 | biostudies-literature
| S-EPMC9825149 | biostudies-literature
| S-EPMC8981362 | biostudies-literature
| S-EPMC4066482 | biostudies-literature
| S-EPMC10029082 | biostudies-literature
| S-EPMC10550912 | biostudies-literature
| S-EPMC8007695 | biostudies-literature
| S-EPMC8174554 | biostudies-literature